NCT00272727

Brief Summary

The purpose of the study is to assess if a dialog tool can improve compliance and asthma control in patients with asthma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable asthma

Timeline
Completed

Started Feb 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 4, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 9, 2006

Completed
23 days until next milestone

Study Start

First participant enrolled

February 1, 2006

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2007

Completed
Last Updated

January 24, 2011

Status Verified

January 1, 2011

First QC Date

January 4, 2006

Last Update Submit

January 21, 2011

Conditions

Asthma

Keywords

Asthmadialog toolcompliance

Outcome Measures

Primary Outcomes (1)

  • ACQ

Secondary Outcomes (1)

  • Ability to follow prescription, AQLQ, lung function, No, eosinophil

Interventions

Dialog tool for caregiversBEHAVIORAL

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosis of asthma \>/= 3 months,
  • Prescribed daily use of inhaled glucocorticosteroid

You may not qualify if:

  • Asthma exacerbation within the last month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Research Site

Copenhagen, Denmark

Location

MeSH Terms

Conditions

AsthmaPatient Compliance

Interventions

Caregivers

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Health PersonnelHealth Care Facilities Workforce and Services

Study Officials

  • AstraZeneca Denmark Medical Director, MD

    AstraZeneca

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

January 4, 2006

First Posted

January 9, 2006

Study Start

February 1, 2006

Study Completion

May 1, 2007

Last Updated

January 24, 2011

Record last verified: 2011-01

Locations

DK(1)